Metabolomics Workbench : NIH Data Repository

Clustering data with hclust algorithm for Differences in mycoplasma growth due to different mediums (Study ST000423)

UPLC POSITIVE ION MODE (Analysis AN000671)

Metabolite	Structure	F1	F2
TG (56:2)	ME148900	0.67	1.33
TG (48:1)	ME148882	0.68	1.32
PC (p-34:1) or PC (o-34:2)	ME148847	0.69	1.31
SM (d34:2)	ME148868	0.69	1.31
TG (50:1)	ME148886	0.73	1.27
PC (36:2)	ME148827	0.70	1.30
PC (40:6)	ME148838	0.71	1.29
Cholesterol	ME148804	0.71	1.29
LPC (18:1)	ME148811	0.71	1.29
TG (54:6)	ME148898	0.61	1.39
TG (48:2)	ME148883	0.53	1.28
TG (56:4)	ME148901	0.58	1.32
TG (54:1)	ME148894	0.62	1.75
PC (38:2)	ME148831	0.54	1.46
TG (14:0/14:0/14:0)	ME148879	0.54	1.46
TG (52:3)	ME148892	0.48	1.52
PC (36:3)	ME148828	0.51	1.49
TG (54:2)	ME148895	0.50	1.50
TG (52:4)	ME148893	0.25	1.75
LPC (16:0)	ME148809	0.40	1.60
PC (34:2)	ME148822	0.41	1.59
TG (50:2)	ME148887	0.33	1.67
LPC (18:0)	ME148810	0.36	1.64
PC (38:3)	ME148832	0.37	1.63
SM (d43:2)	ME148878	1.10	0.39
PC (p-42:3) or PC (o-42:4)	ME148857	1.00	NA
PC (30:1)	ME148814	1.00	NA
PC (28:0)	ME148812	1.00	NA
CE (22:6)	ME148799	1.00	NA
CE (18:1)	ME148797	1.00	NA
CE (20:4)	ME148798	1.00	NA
PC (o-34:0)	ME148845	1.53	0.47
PE (p-40:5) or PE (o-40:6)	ME148864	1.53	0.47
PC (p-40:3) or PC (o-40:4)	ME148854	1.48	0.52
TG (52:1)	ME148890	1.51	0.49
PC (p-42:5) or PC (o-42:6)	ME148859	1.49	0.51
GlcCer (d42:1)	ME148807	1.50	0.50
PC (34:0)	ME148820	1.50	0.50
Ceramide (d18:1/23:0)	ME148800	1.51	0.58
PC (38:4)	ME148833	1.46	0.54
PC (p-40:4) or PC (o-40:5)	ME148855	1.46	0.54
PC (32:1)	ME148817	1.41	0.59
PC (p-38:5) or PC (o-38:6)	ME148853	1.43	0.57
PC (p-40:6) or PC (o-40:7)	ME148856	1.44	0.56
TG (56:5)	ME148902	1.40	0.66
PC (p-42:4) or PC (o-42:5)	ME148858	1.36	0.64
PC (42:5)	ME148841	1.36	0.64
PC (p-38:4) or PC (o-38:5)	ME148852	1.36	0.64
PC (p-36:3) or PC (o-36:4)	ME148849	1.37	0.63
TG (54:3)	ME148896	1.37	0.63
PE (p-38:5) or PE (o-38:6)	ME148863	1.34	0.66
PC (p-34:0) or PC (o-34:1)	ME148846	1.33	0.67
TG (50:0)	ME148885	1.33	0.67
SM (d39:1)	ME148871	1.32	0.52
TG (58:6)	ME148907	1.37	0.56
TG (60:2)	ME148909	1.50	0.40
Gal-Gal-Cer(d18:1/16:0) or Lactosylceramide(d18:1/16:0)	ME148805	1.56	0.44
TG (58:1)	ME148904	1.57	0.43
PC (35:1)	ME148825	1.64	0.36
SM (d42:1)	ME148875	1.62	0.38
SM (d41:2)	ME148874	1.63	0.37
PC (p-38:3) or PC (o-38:4)	ME148851	1.63	0.37
SM (d36:1)	ME148869	1.63	0.37
PC (30:0)	ME148813	1.61	0.39
PC (33:0)	ME148818	1.60	0.40
PC (36:5)	ME148830	1.59	0.41
PC (o-32:0)	ME148844	1.59	0.41
SM (d40:1)	ME148872	1.80	0.20
Ceramide (d40:1)	ME148801	1.76	0.24
PC (33:1)	ME148819	1.78	0.22
GlcCer (d40:1)	ME148806	1.68	0.32
Ceramide (d42:1)	ME148802	1.67	0.33
SM (d32:1)	ME148865	1.67	0.33
PC (31:0)	ME148815	1.73	0.27
PC (34:4)	ME148824	1.72	0.28
SM (d38:1)	ME148870	1.71	0.29
PC (40:7)	ME148839	1.12	0.88
SM (d33:1)	ME148866	1.12	0.88
PC (34:3)	ME148823	1.14	0.86
PC (p-36:1) or PC (o-36:2)	ME148848	1.15	0.85
PC (p-36:4) or PC (o-36:5)	ME148850	1.15	0.85
SM (d41:1)	ME148873	1.27	0.73
TG (58:2)	ME148905	1.28	0.72
PC (34:1)	ME148821	1.20	0.80
SM (d42:2)	ME148876	1.20	0.80
PC (40:5)	ME148837	1.19	0.81
PC (42:7)	ME148843	1.19	0.81
PC (40:8)	ME148840	1.17	0.83
TG (58:8)	ME148908	1.19	0.84
TG (52:0)	ME148889	1.22	0.73
TG (52:2)	ME148891	1.21	0.79
Ceramide (d42:2)	ME148803	1.23	0.77
PC (38:5)	ME148834	1.23	0.77
PC (36:1)	ME148826	1.22	0.78
SM (d42:3)	ME148877	1.22	0.78
GlcCer (d42:2)	ME148808	0.86	1.14
PC (36:4)	ME148829	0.88	1.12
PC (38:6)	ME148835	0.84	1.16
TG (46:0)	ME148880	0.82	1.18
TG (54:4)	ME148897	0.81	1.19
PC (42:6)	ME148842	1.08	0.92
SM (d34:1)	ME148867	1.04	0.96
TG (56:6)	ME148903	1.04	0.96
PE (p-36:4) or PE (o-36:5)	ME148861	1.05	0.95
PC (32:0)	ME148816	1.06	0.94
TG (58:4)	ME148906	1.06	0.94
PE (38:6)	ME148860	0.92	1.08
TG (56:1)	ME148899	0.94	1.06
PC (40:4)	ME148836	0.93	1.07
TG (48:0)	ME148881	0.93	1.07
PE (p-38:4) or PE (o-38:5)	ME148862	1.01	0.99
TG (49:0)	ME148884	0.99	1.03
TG (51:1)	ME148888	0.99	1.03

Factors:

F1	Treatment:Bone marrow macrophage
F2	Treatment:Resident macrophage

Data matrix